Retatrutide has not been approved by the FDA, but precisely one 79-year-old man was granted access via "compassionate use." There’s only one person in the country the FDA has granted access to retatrutide on a “compassionate use” basis: a man who was 79 at the time of his application in April, whose application was personally overseen by a senior doctor at the National Institutes of Health and subsequently approved by the FDA. Three anonymous sources flagged the highly unusual approval to Stat